Vertex Just Spent $10 Billion to Stop Being a One-Disease Company
July 17, 2026 Vertex Just Spent $10 Billion to Stop Being a One-Disease Company The Crinetics deal is expected to…
July 17, 2026 Vertex Just Spent $10 Billion to Stop Being a One-Disease Company The Crinetics deal is expected to…
Richemont’s blowout quarter lit up the sector. LVMH reports July 27.
Every AI agent needs an identity. Okta wants to be the gatekeeper.
July 16, 2026 VLO Options Are Buying Time Big August call volume points past earnings, not at it. Sponsored First…
Q2 results beat on every major line. The installed base business is becoming a second growth engine.
A federal permit process now moving faster than any point in 40 years could unlock the most unconventional critical minerals play on the market.
July 15, 2026 NFLX Options Are Paying For A Gap Earnings week pricing implies about an 8% move into July…
Mounjaro sales up 125% in Q1. A new pill just launched. Q2 earnings could reset the story again.
Revenue grew 33% in Q1. The AI cloud pivot could change everything.
July 14, 2026 A 3-Day Options Signal in FA One strike, zero prior open interest, and a rush into calls.…